Plasma NfL is regarded as a nonspecific marker of axonal damage, and may be a better marker of cognitive decline and neuroimaging changes because it is sensitive to multiple pathologies such as AD-related neurodegeneration, cerebrovascular disease, traumatic brain injury, and TDP-43-related pathology [12, 44]. The gene discussed is TARDBP; the disease is Mental deterioration.